A Study of Evorpacept (ALX148) in Patients With Advanced Solid Tumors and Lymphoma (ASPEN-01)
ALX Oncology Inc.
ALX Oncology Inc.
Amgen
Novartis
Hoffmann-La Roche
Meiji Seika Pharma Co., Ltd.
University of California, San Francisco
National Cancer Institute (NCI)
Pfizer